KEMIA
Kémia operates as a pharmaceutical company. The company discovers and develops small molecule therapeutics. It offers allosteric kinase inhibitors for the treatment of inflammatory diseases, such as rheumatoid arthritis, as well as for cardiovascular and metabolic conditions; and modulators of G protein-coupled receptors. The company specializes in the fields of medicinal and analytical chemistry, biology, pharmacology, pharmacokinetics, pharmacodynamics, and clinical development.
KEMIA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2001-01-01
Address:
San Diego, California, United States
Country:
United States
Total Employee:
11+
Status:
Active
Contact:
(858) 964-1414
Total Funding:
100 M USD
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
MyDx, Inc.
MyDx, Inc. is a science and technology company based in San Diego, California.
ValueGene
ValueGene is an oligonucleotide synthesis services company based in San Diego, California.
Current Employees Featured
Investors List
Hamilton BioVentures
Hamilton BioVentures investment in Series C - Kemia
Red Abbey Venture Partners
Red Abbey Venture Partners investment in Series C - Kemia
JPMorgan Partners
JPMorgan Partners investment in Series C - Kemia
Aberdare Ventures
Aberdare Ventures investment in Series C - Kemia
Forward Ventures
Forward Ventures investment in Series C - Kemia
MedImmune Ventures
MedImmune Ventures investment in Series C - Kemia
Novartis Venture Fund
Novartis Venture Fund investment in Series C - Kemia
JP Morgan Chase
JP Morgan Chase investment in Series B - Kemia
Forward Ventures
Forward Ventures investment in Series B - Kemia
Forward Ventures
Forward Ventures investment in Series A - Kemia